Anjali Avadhani

Anjali Avadhani is currently the Vice President of Therapeutic Studies at Tempus Labs, Inc., a position held since April 2022. Prior experience includes extensive roles at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2014 to March 2022, encompassing leadership positions such as Senior Medical Director for both Early and Late Development in Oncology, as well as Director and Associate Director roles in Clinical Research for Oncology. Anjali Avadhani's educational background includes a Doctor of Medicine (MD) and Bachelor of Arts (BA) from the University of Pennsylvania, along with an Internship and Residency in Internal Medicine from the University of Chicago, and a Fellowship in Hematology/Oncology from the University of Pennsylvania.